SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041391
Filing Date
2019-11-07
Accepted
2019-11-07 09:01:26
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20190930.htm 10-Q 2395193
2 EX-10.1 kzr-ex101_11.htm EX-10.1 148185
3 EX-31.1 kzr-ex311_6.htm EX-31.1 19889
4 EX-31.2 kzr-ex312_8.htm EX-31.2 20033
5 EX-32.1 kzr-ex321_7.htm EX-32.1 9212
6 GRAPHIC gggxehsldtls000001.jpg GRAPHIC 30984
  Complete submission text file 0001564590-19-041391.txt   7274609

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kzr-20190930.xml EX-101.INS 1510951
8 XBRL TAXONOMY EXTENSION SCHEMA kzr-20190930.xsd EX-101.SCH 43638
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20190930_cal.xml EX-101.CAL 49438
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20190930_def.xml EX-101.DEF 110398
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20190930_lab.xml EX-101.LAB 351753
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20190930_pre.xml EX-101.PRE 263127
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 191198322
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences